PKH Ventures IPO opens today: GMP, price, other details. Apply or not?

Here we list out important PKH Ventures IPO details that you may want to know before applying:

1] PKH Ventures IPO GMP: Shares of PKH Ventures Limited are available at a premium of ₹6 per share in grey market today, say market observers.

2] PKH Ventures IPO price: The company has fixed price band of the its public offer at ₹140 to ₹148 per share.

3] PKH Ventures IPO date: The public issue will remain open for subscribers from 30th June 2023 to 4th July 2023.

4] PKH Ventures IPO size: The company aims to raise ₹379.35 crore out of which ₹270.22 crore will be raised through issuance of fresh shares.

5] PKH Ventures IPO lot size: A bidder will be able to apply in lots and one lot will comprise 100 shares of the company.

6] PKH Ventures IPO allotment date: Announcement of share allocation is most likely on Friday, 7 July 2023,

7] PKH Ventures IPO listing: The public issue is proposed for listing on NSE and BSE and likely date for share listing is 12th July 2023.

8] PKH Ventures IPO registrar: Link Intime India Private Ltd has been appointed as official registrar of the initial public offer.

9] PKH Ventures IPO review: Giving ‘buy’ tag to the public offer, Reliance Securities said, “On FY22 financials, the IPO is valued at 30x P/E, 24.5x EV/EBITDA and 6.5x EV/Sales, at the upper price band. The company is poised for growth in the coming years led by multiple projects in the pipeline. The company has been awarded with 3 Government Hotel Development Projects, while subsidiary Garuda Construction is currently engaged in the Civil Construction of 6 residential projects. PKH is also undertaking several Forthcoming Development Projects. Considering the healthy business prospects, decent financials, expertise in the Hospitality vertical, synergies led by acquisition of Amar Remedies and experienced management, we recommend SUBSCRIBE to the issue.”

Before listing on BSE and NSE, the company is in the process of acquiring listed entity Amar Remedies.

“PKH Ventures is in the process of acquiring a NSE and BSE listed public company, Amar Remedies, through the IBC process for a lumpsum consideration of ₹31.59 crore,” says Axis Capital report on PKH Ventures IPO.

PKH Ventures IPO financials

During FY0-22, its revenue/EBITDA/Adj. PAT has grown at a CAGR of 10%/127%/70%. For FY22, its revenue was at Rs1,994mn while EBITDA stood at Rs530mn. EBIDTA margin increased significantly from 6.2% in FY20 to 26.6% in FY22. Adj. PAT during FY20, FY21 and FY22 stood at Rs141mn, Rs306mn and Rs405mn respectively. Return ratios are healthy with average RoE/RoCE of 8.5%/4.6% during FY20-22. Average Net Asset Turnover during FY20-22 was at 1.7x.

Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.

Updated: 30 Jun 2023, 08:33 AM IST